Cargando…

Association of growth differentiation factor-15 level with adverse outcomes in patients with stable coronary artery disease: A meta-analysis

BACKGROUND AND AIMS: Studies on the association between growth-differentiation factor-15 (GDF-15) level and adverse outcomes have yielded conflicting results in patients with stable coronary artery disease (CAD). This meta-analysis aimed to evaluate the association of baseline GDF-15 level with adve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Tingjian, Chen, Youjin, Ye, Tingting, Zheng, Lin, Chen, Luo, Fan, Yuncao, Lin, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833259/ https://www.ncbi.nlm.nih.gov/pubmed/36643602 http://dx.doi.org/10.1016/j.athplu.2021.11.003

Ejemplares similares

Serum sclerostin and adverse outcomes in elderly patients with stable coronary artery disease undergoing percutaneous coronary intervention
por: He, Wuyang, et al.
Publicado: (2019)

Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study
por: Farhan, Serdar, et al.
Publicado: (2016)

Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease
por: Li, Man, et al.
Publicado: (2020)

Roles of Growth Differentiation Factor 15 in Atherosclerosis and Coronary Artery Disease
por: Wang, Juan, et al.
Publicado: (2019)

Growth differentiation factor 15 is increased in stable MS
por: Amstad, Andrea, et al.
Publicado: (2020)

Evaluation of Growth Differentiation Factor-15 in Patients with or without Coronary Artery Disease
por: Hassanzadeh Daloee, Shima, et al.
Publicado: (2021)

Growth Differentiation Factor 15 May Predict Mortality of Peripheral and Coronary Artery Diseases and Correlate with Their Risk Factors
por: Hsu, Lung-An, et al.
Publicado: (2017)

Prognostic value of growth differentiation factor-15 in patients with coronary artery disease: A meta-analysis and systematic review
por: Zhang, Song, et al.
Publicado: (2023)

Growth differentiation factor-15 is a prognostic marker in patients with intermediate coronary artery disease
por: Wang, Wei, et al.
Publicado: (2020)

Validity of inducible ischaemia as a surrogate for adverse outcomes in stable coronary artery disease
por: Timmis, Adam, et al.
Publicado: (2018)

Tetranectin as a Potential Biomarker for Stable Coronary Artery Disease
por: Chen, Yanjia, et al.
Publicado: (2015)

Plasma osteoprotegerin predicts adverse cardiovascular events in stable coronary artery disease: the PEACE trial
por: Ma, Teng, et al.
Publicado: (2023)

Serum growth differentiation factor-15 and non-esterified fatty acid levels in patients with coronary artery disease and hyperuricemia
por: Cheng, Jingru, et al.
Publicado: (2023)

Impact of Clinical Guideline Recommendations on the Application of Coronary Computed Tomographic Angiography in Patients with Suspected Stable Coronary Artery Disease
por: Zhou, Jia, et al.
Publicado: (2016)

Plasma levels of growth differentiation factor-15 are associated with myocardial injury in patients undergoing off-pump coronary artery bypass grafting
por: Yuan, Zhize, et al.
Publicado: (2016)

Study on syndrome differentiation and treatment in the management of chronic stable coronary artery disease to improve quality of life
por: Bi, Ying-Fei, et al.
Publicado: (2018)

Assessing the association of appropriateness of coronary revascularization and 1-year clinical outcomes for patients with stable coronary artery disease in China
por: Lin, Shen, et al.
Publicado: (2020)

Optimal achieved blood pressure for patients with stable coronary artery disease
por: Huang, Chin-Chou, et al.
Publicado: (2017)

Influence of hypercholesterolemia and diabetes on long-term outcome in patients with stable coronary artery disease receiving percutaneous coronary intervention
por: Lin, Mao-Jen, et al.
Publicado: (2019)

Association between cardiac autonomic nervous dysfunction and the severity of coronary lesions in patients with stable coronary artery disease
por: Chen, Yafei, et al.
Publicado: (2018)

Relation Between Plasma Proteomics Analysis and Major Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease
por: Dregoesc, Mihaela Ioana, et al.
Publicado: (2022)

Association Between Circulating Retinol-Binding Protein 4 and Adverse Cardiovascular Events in Stable Coronary Artery Disease
por: Qian, Ke, et al.
Publicado: (2022)

Contemporary Management of Stable Coronary Artery Disease
por: Bertolone, Dario Tino, et al.
Publicado: (2022)

Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease
por: Zhang, Ping, et al.
Publicado: (2020)

Association of Fibrinogen with Severity of Stable Coronary Artery Disease in Patients with Type 2 Diabetic Mellitus
por: Hong, Li-Feng, et al.
Publicado: (2014)

Potential relation between soluble growth differentiation factor-15 and testosterone deficiency in male patients with coronary artery disease
por: Liu, Huan, et al.
Publicado: (2019)

Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass
por: Kahli, Abdelkader, et al.
Publicado: (2014)

Impact of admission triglyceride for early outcome in diabetic patients with stable coronary artery disease
por: Li, Xiao-Lin, et al.
Publicado: (2014)

Growth differentiation factor-15 levels in the blood around the pulmonary artery is associated with hospitalization for heart failure in patients with pulmonary arterial hypertension
por: Chang, Wei-Ting, et al.
Publicado: (2020)

Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player
por: Wesseling, Marian, et al.
Publicado: (2020)

Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Jianan, et al.
Publicado: (2021)

Coronary Revascularization in Patients With Stable Coronary Artery Disease: The Role of Imaging
por: Neglia, Danilo, et al.
Publicado: (2021)

Effects of percutaneous coronary intervention on dyspnea in stable coronary artery disease
por: Wester, Michael, et al.
Publicado: (2022)

Two-year prognostic value of mean platelet volume in patients with diabetes and stable coronary artery disease undergoing elective percutaneous coronary intervention
por: Jiang, Ping, et al.
Publicado: (2019)

Assessing the Associations of Growth Differentiation Factor 15 with Rheumatic Diseases Using Genetic Data
por: Ye, Ding, et al.
Publicado: (2021)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

Impact of Smoking Status on Growth Differentiation Factor 15 and Mortality in Patients With Suspected or Known Coronary Artery Disease: The ANOX Study
por: Wada, Hiromichi, et al.
Publicado: (2020)

Mean Corpuscular Volume Predicts In-Stent Restenosis Risk for Stable Coronary Artery Disease Patients Receiving Elective Percutaneous Coronary Intervention
por: Sun, Lin, et al.
Publicado: (2019)

The effects of remote ischaemic preconditioning on coronary artery function in patients with stable coronary artery disease
por: Corcoran, D., et al.
Publicado: (2018)

Prognostic Impacts of Comorbid Significant Coronary Stenosis and Coronary Artery Spasm in Patients With Stable Coronary Artery Disease
por: Hao, Kiyotaka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6uh1mure62526aafe589od97vo